Tokyo, Japan

Masanori Minoguchi



Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 36(Granted Patents)


Location History:

  • Kiyose, JP (1993 - 1994)
  • Tokyo, JP (1993 - 2011)
  • Osaka, JP (2013 - 2014)

Company Filing History:


Years Active: 1993-2014

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Masanori Minoguchi: Innovator in Pharmaceutical Compounds

Introduction

Masanori Minoguchi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzimidazole compounds. With a total of 10 patents to his name, Minoguchi continues to push the boundaries of medical science.

Latest Patents

Among his latest patents, Minoguchi has developed a benzimidazole compound and its pharmaceutical use. This invention provides an ORL-1 receptor agonist that boasts improved bioavailability due to superior metabolic stability and high selectivity compared to conventional compounds. Another notable patent involves a benzimidazole compound in crystal form and its salt. This invention aims to provide a stable form of a specific compound that is free from issues related to water adsorption and demonstrates enhanced water solubility.

Career Highlights

Minoguchi has worked with leading companies in the pharmaceutical industry, including Mitsubishi Tanabe Pharma Corporation and Mitsubishi Pharma Corporation. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking innovations in drug development.

Collaborations

Throughout his career, Minoguchi has collaborated with notable colleagues such as Satoru Kumazawa and Koji Teshima. These partnerships have fostered a creative environment that has led to significant advancements in their respective fields.

Conclusion

Masanori Minoguchi is a distinguished inventor whose work in pharmaceutical compounds has made a lasting impact. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…